Patrick D. Spangler is Director at OptimizeRx Corp (OPRX). They have made 3 open-market trades across 1 company since 2007, most recently 2026-06-09.
CIK 0001296525
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $945 since 2018, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OPRX | SELL | 2025-08-28 | 2025-09-11 | $17.49 | $389K | +3.1% | +1.4% | -24.9% |
| OPRX | SELL | 2021-11-11 | 2021-11-15 | $84.38 | $1.1M | -12.2% | -28.8% | -45.0% |
| OPRX | BUY | 2018-06-27 | 2018-06-28 | $9.95 | $945 | +1.1% | -2.7% | +72.6% |
| EVVV | SELL · 10b5-1 | 2008-11-17 | 2008-11-18 | $5.16 | $12K | N/A | N/A | N/A |
| EVVV | SELL · 10b5-1 | 2007-11-16 | 2007-11-19 | $15.05 | $25K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.